Caricamento...
A100 THE UNFINISHED SYMPHONY: GOLIMUMAB IS EFFICIENT AS SALVAGE THERAPY IN PATIENTS WITH REFRACTORY CROHN’S DISEASE
BACKGROUND: Golimumab is a fully human, IgG1k monoclonal antibody against anti–tumor necrosis factor (anti-TNF) agent approved for the treatment of moderate-to-severely active ulcerative colitis. However, there have been no formal trials to date to assess its utility in Crohn’s disease (CD). AIMS: T...
Salvato in:
| Pubblicato in: | J Can Assoc Gastroenterol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507753/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.101 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|